The invention relates to pharmaceutical compositions and methods of treating inflammatory-related diseases associated with pro-inflammatory cytokine expression andor reduced expression of anti-inflammatory cytokines. The light source part comprises a light emitting diode and a circuit board on which the light emitting diode is disposed. A first switch sends a barrier command signal to the head unit commanding the head unit to open or close a movable barrier. The software wrapper also includes a software license key identifying a license policy specifying a use limitation within a geographic boundary. The surface processing layer extends from inside the opening of the pixel defining layer to a top surface of the pixel defining layer. These elastomer compositions comprise reaction products of polyisocyanates and telechelic polymers having isocyanate-reactive end-groups such as hydroxyl groups andor amine groups.